Table 3 Outcome parameters
Parameter | Study group |
|---|---|
(n = 208) | |
Haemoglobin (g/dl) | |
- before surgery | 13.8 (9.1 – 18.0) |
- after surgery (day 1) | 12.7 (7.9 – 15.9) |
- difference | -1.0 (-0.8 – 4.7) |
Leukocytes (109/l) | |
- before surgery | 6.8 (3.5 – 13.3) |
- after surgery | 8.3 (2.8 – 19.1) |
- difference | +1.5 (-7.0 – 7.8) |
Drainage – n (%) | 206 (99.0%) |
Duration of drainage (in days) | |
- < 3 d | 47 (22.6%) |
- 3–5 d | 151 (72.6%) |
- > 5 d | 7 (3.4%) |
- unknown | 3 (1.5%) |
Palpable Seroma breast – n (%) | 8 (3.8%) |
- needle aspiration | 2 (25.0%) |
- no needle aspiration | 6 (75%) |
Palpable Seroma axilla – n (%) | 28 (13.5%) |
- needle aspiration once | 11 (39.3%) |
- needle aspiration twice | 6 (21.4%) |
- needle aspiration three times | 5 (17.9%) |
- no needle aspiration | 6 (21.4%) |
Haematoma/suggillation breast – n (%) | 50 (24.0%) |
- surgical revision | 2 (1.0%) |
Haematom axilla – n (%) | 22 (10.6%) |
- surgical revision | 1 (0.5%) |
Inconspicuous woundhealing– n (%) | 86 (41.3%) |
Erythema Grade I-II – n (%) | 27 (13.0%) |
Mastitis – n (%) | 7 (3.4%) |
Fever – n (%) | 22 (10.6%) |
Therapeutic antibiotic treatment – n (%) | 75 (36.1%) |
Induration toumor bed – n (%) | 17 (8.2%) |
Retraction of the scar– n (%) | 2 (1.0%) |
Postoperative pain reliever -n (%) | |
- on demand | 28 (13.5%) |
- regular | 79 (38.0%) |
Nausea postop– n (%) | 3 (1.4%) |
Duration of hospital stay (in days) | |
- < 7 | 12 (5.8%) |
- 7 – 10 | 126 (60.5%) |
- > 10 | 70 (33.7%) |